A Waltham developer of stem cell technologies, Minerva Biotechnologies, will begin selling what it calls "breakthrough" stem cells to researchers and biotechnology companies thanks to two recent licensing agreements with Japanese companies. The deal opens up the possibility for researchers to grow human organs in animals that can then be transplanted. “This whole field is moving quickly,” said Dr.